Anaplastic thyroid carcinoma: a 25-year single-institution experience

A Mohebati1, M Dilorenzo, F Palmer

  • 1Head and Neck Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

Annals of Surgical Oncology
|February 21, 2014
PubMed
Summary

Anaplastic thyroid carcinoma (ATC) survival is poor, but aggressive treatment improves outcomes. Multimodality therapy including surgery and radiation offers the best chance for patients with limited disease.